Fate Therapeutics, Inc. Competitors

FATE 
$6.14
*  
0.05
0.81%
Get FATE Alerts
*Delayed - data as of May 26, 2015  -  Find a broker to begin trading FATE now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FATE Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Biotechnology: Biological Products (No Diagnostic Substances)

Fate Therapeutics, Inc.

CompanyName
Symbol: Market
LastSale NetChange Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap ▼
Gilead Sciences, Inc.
GILD: NASDAQ-GS
$ 109.77 -1.94 ▼ 16,005,445 $ 111.53
$ 109.54
$ 116.83
$ 78.50
12.46 163,491,657,540
Amgen Inc.
AMGN: NASDAQ-GS
$ 159.01 -4.57 ▼ 4,077,165 $ 162.46
$ 158
$ 173.60
$ 113.56
21.46 120,666,487,610
Biogen Inc.
BIIB: NASDAQ-GS
$ 392.88 -5.80 ▼ 897,530 $ 399.9279
$ 391.6196
$ 480.18
$ 290.85
28.35 92,175,148,320
Synageva BioPharma Corp.
GEVA: NASDAQ-GS
$ 213.995 -4.12 ▼ 876,595 $ 218
$ 213.57
$ 218.80
$ 60.19
NE 7,908,827,210
bluebird bio, Inc.
BLUE: NASDAQ-GS
$ 183.69 5.31 ▲ 1,138,100 $ 189.06
$ 177.06
$ 186.36
$ 20.01
NE 5,982,048,540
Qiagen N.V.
QGEN: NASDAQ-GS
$ 24.83 -0.28 ▼ 870,991 $ 24.915
$ 24.665
$ 25.91
$ 20.73
52.83 5,794,204,650
Seattle Genetics, Inc.
SGEN: NASDAQ-GS
$ 42.81 -0.42 ▼ 1,145,292 $ 43.58
$ 42.5348
$ 44.95
$ 30.05
NE 5,322,096,390
Juno Therapeutics, Inc.
JUNO: NASDAQ-GS
$ 46.45 -0.33 ▼ 482,875 $ 47.15
$ 46.16
$ 66
$ 34.71
NE 4,200,287,700
Bio-Techne Corp
TECH: NASDAQ-GS
$ 102.04 -0.57 ▼ 114,601 $ 102.74
$ 101.65
$ 103.38
$ 85.96
35.19 3,789,153,360
Neurocrine Biosciences, Inc.
NBIX: NASDAQ-GS
$ 42.30 -0.25 ▼ 749,216 $ 42.91
$ 41.31
$ 45.36
$ 12.6325
NE 3,604,213,800
China Biologic Products, Inc.
CBPO: NASDAQ-GS
$ 109.18 -0.06 ▼ 75,556 $ 109.78
$ 108.48
$ 109.26
$ 37.50
37.65 2,692,051,260
Novavax, Inc.
NVAX: NASDAQ-GS
$ 8.89 0.02 ▲ 1,568,168 $ 8.92
$ 8.77
$ 9.95
$ 3.92
NE 2,381,142,050
Halozyme Therapeutics, Inc.
HALO: NASDAQ-GS
$ 17.74 0.29 ▲ 1,956,877 $ 17.867
$ 17.15
$ 17.63
$ 7.51
NE 2,224,365,380
Kite Pharma, Inc.
KITE: NASDAQ-GS
$ 51.21 -1.64 ▼ 1,021,269 $ 53.50
$ 50.51
$ 89.21
$ 21
NE 2,177,500,410
ARIAD Pharmaceuticals, Inc.
ARIA: NASDAQ-GS
$ 8.96 -0.11 ▼ 2,479,806 $ 9.08
$ 8.85
$ 9.89
$ 4.90
NE 1,677,419,520
Spark Therapeutics, Inc.
ONCE: NASDAQ-GS
$ 68.28 0.75 ▲ 125,289 $ 68.56
$ 66.11
$ 79.50
$ 40.16
NE 1,675,864,320
Acorda Therapeutics, Inc.
ACOR: NASDAQ-GS
$ 31.61 -0.40 ▼ 697,041 $ 32.23
$ 31.32
$ 45.45
$ 28.26
95.79 1,345,795,750
Repligen Corporation
RGEN: NASDAQ-GS
$ 40.51 -0.37 ▼ 439,211 $ 41.35
$ 39.722
$ 42.43
$ 18.23
192.9 1,325,568,220
Cellectis S.A.
CLLS: NASDAQ-GM
$ 36.45 2.45 ▲ 615,690 $ 36.84
$ 34.71
$ 42.04
$ 30.40
NE 1,201,720,050
Acceleron Pharma Inc.
XLRN: NASDAQ-GM
$ 33.39 0.47 ▲ 128,640 $ 33.57
$ 32.32
$ 48.50
$ 23.61
NE 1,076,927,670
PDL BioPharma, Inc.
PDLI: NASDAQ-GS
$ 6.61 -0.05 ▼ 1,223,053 $ 6.65
$ 6.54
$ 10.26
$ 6.38
3.39 1,075,784,110
Momenta Pharmaceuticals, Inc.
MNTA: NASDAQ-GS
$ 19.39 -0.49 ▼ 983,898 $ 19.83
$ 18.97
$ 20.75
$ 9.38
NE 1,065,926,470
Adaptimmune Therapeutics plc
ADAP: NASDAQ-GS
$ 15.23 -0.37 ▼ 126,758 $ 15.75
$ 15.06
$ 19.50
$ 14
NE 1,049,499,300
Coherus BioSciences, Inc.
CHRS: NASDAQ-GM
$ 25.12 0.14 ▲ 107,424 $ 25.14
$ 24.63
$ 33.30
$ 12.27
NE 950,565,920
Atara Biotherapeutics, Inc.
ATRA: NASDAQ-GS
$ 38.54 0.81 ▲ 90,686 $ 39.21
$ 37.515
$ 64.35
$ 9.66
NE 938,834,400